当前位置: 首页 > 详情页

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Health Research Methods, Evidence and Impact Canada, McMaster University, Hamilton, Ont. [2]Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China [3]Department of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ont. [4]Department of Critical Care Medicine and Sunnybrook Research Institute , Sunnybrook Health Sciences Centre, Toronto, Ont. [5]Department of Pediatrics, University of British Columbia, Vancouver, BC [6]Department of Medicine, Université de Sherbrooke [7]Centre de recherche du CHUS de Sherbrooke, Sherbrooke, Que. [8]Department of Critical Care Medicine, Zhongda hospital, School of Medicine, Southeast University, Nanjing, China [9]Department of Pharmacy, the First Affiliated Hospital of Guangzhou University of Medical [10]Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China [11]Department of Pathology and Molecular Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ont. [12]Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China [13]Guangdong kuaiwen information technology co. LTD, Guanzhong, China [14]Kunshan Guanghui Precise Metal Co. Ltd., Kunshan, China [15]Intensive Care Department , King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia [16]Department of Clinical Medicine, Health Science Center, Universidad de Guadalajara, Guadalajara, Mexico [17]Department of Critical Care Medicine, Xuanwu Hospital, Capital Medical School, Beijing, China [18]Department of Pulmonary and Critical Care Medicine , University of Ulsan College of Medicine, Seoul, South Korea [19]Department of Pharmacy , Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China [20]Department of Pharmacy, Peking University Third Hospital, Beijing, China [21]Fast and Chronic Programmes, Alexandra Hospital, National University Health System, Singapore [22]Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China [23]General Surgery Department, Peking University Third Hospital, Beijing, China [24]Medical Intensive Care Unit , Peking Union Medical College Hospital, Beijing. [25]Department of Medicine, McMaster University, Hamilton, Ont.
出处:
ISSN:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 2 区 医学:内科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2018]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Health Research Methods, Evidence and Impact Canada, McMaster University, Hamilton, Ont.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院